This study investigated the impact of LDLR 3’ UTR polymorphisms on lipid levels before and after atorvastatin treatment in adult Chinese Han patients with dyslipidemia, offering significant insights into the genetic factors influencing serum lipid regulation and the potential effects on atorvastatin treatment outcomes. Here, LDLR is linked to metabolic syndrome.